Morgan Stanley Novartis Ag Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Novartis Ag stock. As of the latest transaction made, Morgan Stanley holds 7,258,381 shares of NVS stock, worth $749 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,258,381
Previous 7,092,253
2.34%
Holding current value
$749 Million
Previous $716 Million
1.96%
% of portfolio
0.06%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,342Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.28 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.27 Billion0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$621 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$610 Million0.81% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$588 Million0.18% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $222B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...